Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Long-term Debt (Details Textual)

v3.4.0.3
Note 12 - Long-term Debt (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended
Dec. 22, 2015
Jun. 16, 2015
Oct. 31, 2014
Mar. 31, 2016
Oct. 31, 2015
Mar. 31, 2016
Jun. 30, 2015
Mar. 31, 2015
RedPath Integrated Pathology, Inc [Member] | Notes Payable, Other Payables [Member]                
Debt Instrument, Face Amount     $ 11,000,000          
Business Combination, Consideration Transferred, Liabilities Incurred     $ 7,500,000          
Debt Instrument, Interest Rate, Stated Percentage     5.00%          
Interest Expense, Debt           $ 200,000   $ 200,000
RedPath Integrated Pathology, Inc [Member] | Loans Payable [Member]                
Debt Instrument, Face Amount     $ 20,000,000          
Debt Instrument, One Time Payment, Principal         $ 1,333,750      
Proceeds from Issuance of Debt     $ 19,600,000          
RedPath Integrated Pathology, Inc [Member]                
Business Combination, Consideration Transferred, Liabilities Incurred             $ 10,700,000  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares         500,000      
Business Combination, Indemnification Assets, Amount as of Acquisition Date       $ 1,500,000   1,500,000    
Business Combination, Indemnification Assets, Amount as of Acquisition Date, Current       500,000   500,000    
Business Combination, Indemnification Assets, Amount as of Acquisition Date, Noncurrent       1,000,000   1,000,000    
Notes Payable, Other Payables [Member]                
Long-term Debt       8,600,000   8,600,000    
Debt Instrument, Unamortized Discount       $ 2,100,000   2,100,000    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares   500,000 500,000 500,000        
Interest Expense, Debt           $ 203,000   $ 848,000
Business Combination, Indemnification Assets, Amount as of Acquisition Date     $ 500,000          
Payments for Other Fees $ 1,600,000